Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 06, 2011 08:00 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals Provides Update on Continued Promising Data From a Phase 1/2 Clinical Trial of TH-302 at the American Society of Clinical Oncology Annual Meeting

REDWOOD CITY, Calif., June 6, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced clinical trial results related to Threshold's clinical stage hypoxia-activated...
May 12, 2011 16:00 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals Reports First Quarter 2011 Financial and Operational Results

REDWOOD CITY, Calif., May 12, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today reported financial results for the first quarter ended March 31, 2011. The net loss for...
May 09, 2011 08:30 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold to Present at the 10th Annual JMP Securities Research Conference

REDWOOD CITY, Calif., May 9, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced that Dr. Barry Selick, Threshold's chief executive officer, will present at the 10th...
May 03, 2011 16:00 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals Presents Positive Preclinical Results at International Myeloma Workshop

REDWOOD CITY, Calif., May 3, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today announced a presentation of preclinical research on its clinical stage hypoxia-activated...
April 25, 2011 08:30 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Update Since Sudden Death of Its Chief Medical Officer

REDWOOD CITY, Calif., April 25, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today provided an update since the death last week of John G. Curd, M.D., president and chief...
April 21, 2011 08:30 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Announces Unexpected Death of Its Chief Medical Officer

REDWOOD CITY, Calif., April 21, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today announced the death of John G. Curd, M.D., president and chief medical officer. Dr. Curd...
April 12, 2011 16:00 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Announces Presentation and Webcast at BioCentury Future Leaders Conference

REDWOOD CITY, Calif., April 12, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced that Dr. Barry Selick, Threshold's chief executive officer, is scheduled to...
April 04, 2011 16:00 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold to Present at Needham Healthcare Conference

REDWOOD CITY, Calif., April 4, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced that Dr. Barry Selick, Threshold's chief executive officer, will present at the...
April 04, 2011 08:35 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals Presents TH-302 Translational Data in Three Scientific Presentations at AACR Annual Meeting

REDWOOD CITY, Calif., April 4, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced multiple preclinical presentations on its clinical stage hypoxia-activated...
March 24, 2011 08:35 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals Reports Fourth Quarter and Year End 2010 Financial Results

REDWOOD CITY, Calif., March 24, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today reported financial results for the fourth quarter and the year ended December 31,...